drugdeliverybusiness2d
Abbott, Dexcom settle global CGM patent litigation
Abbott (NYSE:ABT) reached an agreement with Dexcom (Nasdaq:DXCM) to settle all outstanding patent disputes between companies.
drugdeliverybusiness2d
BD hit with FDA warning related to Pyxis medication management
The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of ...
drugdeliverybusiness2d
The 5 most-read Drug Delivery Business News stories of 2024
There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.
drugdeliverybusiness6d
Oura raises $200M from investors including Dexcom
[Image courtesy of Dexcom/Oura] Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health monitoring ...
drugdeliverybusiness6d
Vivani Medical initiates first-in-human GLP-1-eluting implant study
The Vivani NanoPortal technology. [Image courtesy of Vivani] Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.